Nicolas Barthelemy

Nicolas Barthelemy is a distinguished professional with extensive experience in the life sciences and biotechnology sectors. Since June 2014, Barthelemy has served on the Board of Directors for Repligen Corporation and has held the position of Executive Chairman at Biocare Medical and Slingshot Biosciences since April 2018 and November 2021, respectively. Additional roles include Senior Advisor at Warburg Pincus LLC since June 2020 and Chairman of the Board of Directors at NanoCellect Biomedical, Inc., with a tenure from July 2021 to August 2024. Barthelemy has been involved as a board member for several companies, including Twist Bioscience, 908 Devices, Fluidigm Corporation, and GENEWIZ, the latter being acquired by Brooks Automation in October 2018. Prior to these roles, Barthelemy served as a Senior Advisor at Merieux Developpement from March 2016 to October 2018. Barthelemy holds a Master's degree in Chemical Engineering from the University of California, Berkeley, and has pursued education at Harvard Business School and Ecole Superieure de Physique et chimie de Paris (ESPCI).